Lentivector Transduction Improves Outcomes Over Transplantation of Human HSCs Alone in NOD/SCID/Fabry Mice | ||
| dc.conicet.organizacion | University Health Network | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | University Health Network | |
| dc.conicet.organizacion | Kagoshima University | |
| dc.conicet.organizacion | University Health Network | |
| dc.conicet.organizacion | University Health Network | |
| dc.conicet.organizacion | University Health Network | |
| dc.conicet.organizacion | University Health Network | |
| dc.conicet.organizacion | Kagoshima University | |
| dc.conicet.organizacion | University Health Network | |
| dc.conicet.organizacion | University of Toronto | |
| dc.contributor.author | Pacienza, Natalia Alejandra | |
| dc.contributor.author | Yoshimitsu, Makoto | |
| dc.contributor.author | Mizue, Nobuo | |
| dc.contributor.author | Au, Bryan C. Y. | |
| dc.contributor.author | Wang, James C. M. | |
| dc.contributor.author | Fan, Xin | |
| dc.contributor.author | Takenaka, Toshihiro | |
| dc.contributor.author | Medin, Jeffrey A | |
| dc.date.issued | 2012-07 | |
| dc.description.abstract | Fabry disease is a lysosomal storage disorder caused by a deficiency of a-galactosidase A (a-gal A) activity that results in progressive globotriaosylceramide (Gb(3)) deposition. We created a fully congenic nonobese diabetic (NOD)/severe combined immunodeficiency (SCID)/Fabry murine line to facilitate the in vivo assessment of human cell-directed therapies for Fabry disease. This pure line was generated after 11 generations of backcrosses and was found, as expected, to have a reduced immune compartment and background a-gal A activity. Next, we transplanted normal human CD34(+) cells transduced with a control (lentiviral vector-enhanced green fluorescent protein (LV-eGFP)) or a therapeutic bicistronic LV (LV-a-gal A/internal ribosome entry site (IRES)/hCD25). While both experimental groups showed similar engraftment levels, only the therapeutic group displayed a significant increase in plasma a-gal A activity. Gb(3) quantification at 12 weeks revealed metabolic correction in the spleen, lung, and liver for both groups. Importantly, only in the therapeutically-transduced cohort was a significant Gb(3) reduction found in the heart and kidney, key target organs for the amelioration of Fabry disease in humans. | es |
| dc.description.fil | Fil: Pacienza, Natalia Alejandra. University Health Network; Canadá. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina | |
| dc.description.fil | Fil: Yoshimitsu, Makoto. Kagoshima University; Japón. University Health Network; Canadá | |
| dc.description.fil | Fil: Mizue, Nobuo. University Health Network; Canadá | |
| dc.description.fil | Fil: Au, Bryan C. Y.. University Health Network; Canadá | |
| dc.description.fil | Fil: Wang, James C. M.. University Health Network; Canadá | |
| dc.description.fil | Fil: Fan, Xin. University Health Network; Canadá | |
| dc.description.fil | Fil: Takenaka, Toshihiro. Kagoshima University; Japón | |
| dc.description.fil | Fil: Medin, Jeffrey A. University Health Network; Canadá. University of Toronto; Canadá | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Pacienza, Natalia Alejandra; Yoshimitsu, Makoto; Mizue, Nobuo; Au, Bryan C. Y.; Wang, James C. M.; et al.; Lentivector Transduction Improves Outcomes Over Transplantation of Human HSCs Alone in NOD/SCID/Fabry Mice; Nature Publishing Group; Molecular Therapy (print); 20; 7; 7-2012; 1454-1461 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1525-0016 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/96175 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 7 | es |
| dc.journal.pagination | 1454-1461 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Molecular Therapy (print) | es |
| dc.journal.volume | 20 | es |
| dc.language.iso | eng | es |
| dc.publisher | Nature Publishing Group | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3393855/ | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.1038%2Fmt.2012.64 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | MOUSE MODEL | es |
| dc.subject | FABRY DISEASE | es |
| dc.subject | GENE THERAPY | es |
| dc.subject | TRANSLACIONAL THERAPY | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.subject.classification | Tecnologías que involucran la identificación de ADN, proteínas y enzimas, y cómo influyen en el conjunto de enfermedades y mantenimiento del bienestar | es |
| dc.subject.classification | Biotecnología de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Lentivector Transduction Improves Outcomes Over Transplantation of Human HSCs Alone in NOD/SCID/Fabry Mice | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.c1fada9f-cf02-40ed-b612-4853ab67212c_A.pdf
- Tamaño:
- 526.81 KB
- Formato:
- Adobe Portable Document Format